MA52088A - Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication - Google Patents

Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication

Info

Publication number: MA52088A
Authority: MA; Morocco
Prior art keywords: arsenite; meta; manufacturing; pharmaceutical composition; composition consisting
Prior art date: 2018-03-22

Application number

MA052088A

Other languages

English (en)

Inventor

Yong-Jin Yang

Original Assignee

Komipharm Int Australia Pty Ltd

Panaphix Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-03-22

Filing date

2019-03-21

Publication date

2021-01-27

2018-03-22 Priority claimed from AU2018900954A external-priority patent/AU2018900954A0/en

2019-03-21 Application filed by Komipharm Int Australia Pty Ltd, Panaphix Inc filed Critical Komipharm Int Australia Pty Ltd

2021-01-27 Publication of MA52088A publication Critical patent/MA52088A/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Diabetes (AREA)
Oncology (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

MA052088A 2018-03-22 2019-03-21 Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication MA52088A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AU2018900954A AU2018900954A0 (en)		2018-03-22	Pharmaceutical composition and method of manufacture

Publications (1)

Publication Number	Publication Date
MA52088A true MA52088A (fr)	2021-01-27

Family

ID=67988234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA052088A MA52088A (fr)	2018-03-22	2019-03-21	Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication

Country Status (21)

Country	Link
US (1)	US12257347B2 (fr)
EP (1)	EP3768247A4 (fr)
JP (1)	JP7419333B2 (fr)
KR (1)	KR102868121B1 (fr)
CN (1)	CN112135608A (fr)
AR (1)	AR114596A1 (fr)
AU (1)	AU2019239671B2 (fr)
BR (1)	BR112020019425A2 (fr)
CA (1)	CA3094115A1 (fr)
CL (1)	CL2020002407A1 (fr)
CO (1)	CO2020012963A2 (fr)
EA (1)	EA202092186A1 (fr)
IL (1)	IL277456B2 (fr)
JO (1)	JOP20200238A1 (fr)
MA (1)	MA52088A (fr)
MX (1)	MX2020009756A (fr)
PE (1)	PE20211479A1 (fr)
PH (1)	PH12020551518A1 (fr)
SG (1)	SG11202009174WA (fr)
WO (1)	WO2019178643A1 (fr)
ZA (1)	ZA202006448B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2022010066A (es) *	2020-02-16	2022-08-25	Komipharm Int Australia Pty Ltd	Metodo para tratamiento usando meta-arsenito.
TW202304457A (zh) *	2021-03-22	2023-02-01	瑞典商阿斯特捷利康公司	配製物
CN113845423B (zh) *	2021-09-10	2023-06-02	安徽山河药用辅料股份有限公司	一种均一片形结构的药用辅料硬脂富马酸钠及其制备方法
EP4455672A1 (fr)	2023-04-26	2024-10-30	Medsenic	Procédé et kit pour diagnostiquer et surveiller la réaction chronique du greffon contre l'hôte (cgvhd) à l'aide de biomarqueurs de cytokine particuliers

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5162117A (en) *	1991-11-22	1992-11-10	Schering Corporation	Controlled release flutamide composition
US5318973A (en) *	1993-06-07	1994-06-07	Vyzkumny Ustav Pro Farmacii A Biochemii	Neuroprotective composition for preventing or treating of central nervous system impairment
JP4036936B2 (ja)	1997-10-22	2008-01-23	古河機械金属株式会社	排酸の処理法
US6262086B1 (en) *	1999-08-26	2001-07-17	Robert R. Whittle	Pharmaceutical unit dosage form
KR20020083678A (ko) *	2001-04-28	2002-11-04	주식회사 한국미생물연구소	아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
WO2003057150A2 (fr) *	2001-12-28	2003-07-17	Teva Pharmaceutical Industries Ltd.	Formulation pharmaceutique d'hydrochlorure stable et procédé de préparation
WO2003086424A1 (fr)	2002-04-10	2003-10-23	Korea Microbiological Laboratories, Ltd.	Composition pharmaceutique comprenant de l'arsenite et destinee au traitement de malignites
WO2005062810A2 (fr)	2003-12-18	2005-07-14	Mediscovery, Llc	Traitement de maladies neoplasiques metastatiques ou primiares avec du decaoxyde d'arsenic
US20090061022A1 (en) *	2004-10-08	2009-03-05	Sang Bong Lee	Pharmaceutical composition comprising arsenite for the treatment of malignancy
WO2006104292A1 (fr)	2005-03-31	2006-10-05	Komipharm International Co., Ltd.	Composition pharmaceutique qui comprend de l’acide arsénique, du meta-arsénite et des sels pharmaceutiquement acceptables
EP1721615A1 (fr)	2005-05-09	2006-11-15	Komipharm International Co., Ltd.	Composition pharmaceutique comprenant de l'arsenite de sodium ou de potassium pour traiter le cancer urogenital et ses métastases
US20070293479A1 (en)	2006-05-18	2007-12-20	Osinga Niels J	Olanzapine pharmaceutical composition
US8945505B2 (en)	2007-02-02	2015-02-03	Panaphix, Inc.	Use of arsenic compounds for treatment of pain and inflammation
JP5769963B2 (ja)	2007-07-23	2015-08-26	ファーマシェンエス．エー．	ジヒドロピリジンカルシウムチャンネルアンタゴニストを含む薬学的組成物とその調製方法
KR20090058423A (ko) *	2007-12-04	2009-06-09	심형섭	소디움 메타아르세나이트를 함유하는 ｃ형 바이러스성 간염치료용 조성물
US20090246291A1 (en)	2008-03-27	2009-10-01	Angelika Burger	Method and compositions for treatment of cancer
US20120045520A1 (en) *	2008-08-21	2012-02-23	Sang Bong Lee	Pharmaceutical composition comprising arsenite for the treatment of malignancy
MX2011005167A (es)	2008-11-20	2011-05-30	Avantor Performance Mat Inc	Excipiente co-procesado basado en fosfato dibasico de calcio, granular, de alta funcionalidad, directamente compresible.
EP2477635A4 (fr)	2009-09-18	2013-03-27	Kominox Inc	Méthodes de traitement de tumeurs cérébrales
TW201129386A (en)	2009-11-05	2011-09-01	Fmc Corp	Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
TWI461213B (zh)	2009-11-05	2014-11-21	Fmc Corp	作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
US20120251628A1 (en)	2011-03-30	2012-10-04	Young Joo Min	Compositions and methods for treatment of cancer
RU2647421C2 (ru)	2012-12-27	2018-03-15	Зентива Саглык Урунлеры Сан. Ве Тыдж. А.Ш.	Способ сухого гранулирования для получения композиций метформина в виде таблеток и его композиции

2019
- 2019-03-21 KR KR1020207030401A patent/KR102868121B1/ko active Active
- 2019-03-21 AR ARP190100727A patent/AR114596A1/es unknown
- 2019-03-21 CN CN201980028836.3A patent/CN112135608A/zh active Pending
- 2019-03-21 EP EP19770346.5A patent/EP3768247A4/fr active Pending
- 2019-03-21 US US16/982,399 patent/US12257347B2/en active Active
- 2019-03-21 EA EA202092186A patent/EA202092186A1/ru unknown
- 2019-03-21 SG SG11202009174WA patent/SG11202009174WA/en unknown
- 2019-03-21 CA CA3094115A patent/CA3094115A1/fr active Pending
- 2019-03-21 AU AU2019239671A patent/AU2019239671B2/en active Active
- 2019-03-21 MX MX2020009756A patent/MX2020009756A/es unknown
- 2019-03-21 JP JP2021500320A patent/JP7419333B2/ja active Active
- 2019-03-21 JO JOP/2020/0238A patent/JOP20200238A1/ar unknown
- 2019-03-21 MA MA052088A patent/MA52088A/fr unknown
- 2019-03-21 IL IL277456A patent/IL277456B2/en unknown
- 2019-03-21 WO PCT/AU2019/050249 patent/WO2019178643A1/fr not_active Ceased
- 2019-03-21 PE PE2020001435A patent/PE20211479A1/es unknown
- 2019-03-21 BR BR112020019425-5A patent/BR112020019425A2/pt unknown
2020
- 2020-09-17 CL CL2020002407A patent/CL2020002407A1/es unknown
- 2020-09-21 PH PH12020551518A patent/PH12020551518A1/en unknown
- 2020-10-16 CO CONC2020/0012963A patent/CO2020012963A2/es unknown
- 2020-10-16 ZA ZA2020/06448A patent/ZA202006448B/en unknown

Also Published As

Publication number	Publication date
JOP20200238A1 (ar)	2020-09-20
US12257347B2 (en)	2025-03-25
ZA202006448B (en)	2026-01-28
JP7419333B2 (ja)	2024-01-22
AR114596A1 (es)	2020-09-23
PH12020551518A1 (en)	2021-07-12
IL277456B2 (en)	2024-11-01
PE20211479A1 (es)	2021-08-05
CN112135608A (zh)	2020-12-25
SG11202009174WA (en)	2020-10-29
WO2019178643A1 (fr)	2019-09-26
KR20210016513A (ko)	2021-02-16
AU2019239671B2 (en)	2025-02-27
AU2019239671A1 (en)	2020-10-01
EP3768247A4 (fr)	2021-12-29
BR112020019425A2 (pt)	2020-12-29
CL2020002407A1 (es)	2021-04-09
JP2021518434A (ja)	2021-08-02
CA3094115A1 (fr)	2019-09-26
EP3768247A1 (fr)	2021-01-27
KR102868121B1 (ko)	2025-10-14
CO2020012963A2 (es)	2020-10-30
IL277456A (en)	2020-11-30
EA202092186A1 (ru)	2020-12-16
IL277456B1 (en)	2024-07-01
MX2020009756A (es)	2021-01-29
US20210000746A1 (en)	2021-01-07

Publication	Publication Date	Title
EP3707317A4 (fr)	2021-09-01	Procédé et appareil de fabrication de précision d'ensembles de liaison de moment
EP3914252A4 (fr)	2022-03-30	Composition pharmaceutique du nilotinib
EP3848972A4 (fr)	2022-06-01	Panneau d'affichage et son procédé de fabrication
EP3799560A4 (fr)	2022-04-13	Vis à os et procédé de fabrication
MA47816A (fr)	2020-01-15	Composition pharmaceutique comprenant du sélexipag
EP3598537A4 (fr)	2020-06-10	Procédé de fabrication de mélange d'électrode et mélange d'électrode
EP3437637A4 (fr)	2019-12-11	Préparation pharmaceutique de palbociclib et son procédé de préparation
EP3832748A4 (fr)	2022-10-05	Panneau d'affichage et son procédé de fabrication
EP3904078A4 (fr)	2022-03-02	Film antireflet et son procédé de production
MA52088A (fr)	2021-01-27	Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication
EP3583644A4 (fr)	2020-11-11	Matériaux d'électrode et leurs procédés de préparation
EP3962457A4 (fr)	2022-11-16	Composition cannabinoïde et procédés de fabrication
EP3890634A4 (fr)	2022-09-28	Vis à os et procédé de fabrication
IL286492A (en)	2021-12-01	Sialidase-resistant saccharide and method of making and using the same
EP4045534A4 (fr)	2023-11-15	Anticorps, composition pharmaceutique et procédé
EP3364237A4 (fr)	2019-05-22	Panneau d'affichage et procédé de fabrication associé
EP3429589A4 (fr)	2020-01-08	Composition pharmaceutique du nilotinib
EP4023227A4 (fr)	2023-09-13	Composition pharmaceutique et son application
EP3437725A4 (fr)	2019-05-01	Membrane d'élimination de virus et procédé de fabrication de membrane d'élimination de virus
EP3818839A4 (fr)	2022-03-09	Capsule triple, appareil et procédé de fabrication associés
EP3854248A4 (fr)	2021-11-17	Chaussures souples de mannequin et procédé de fabrication de telles chaussures
EP3459948A4 (fr)	2020-01-01	Triazolopyridine contenant du fluor et procédé de préparation, composition pharmaceutique et application correspondants
EP3986009A4 (fr)	2022-09-28	Noeud amf et procédé associé
EP3391930A4 (fr)	2019-09-11	Cathéter à ballonnet, procédé de fabrication associé, et procédé de traitement
EP3621659A4 (fr)	2021-01-13	Composition d'administration de médicament et procédé de fabrication